Skip to main content
SpringerLink
Log in

Raised plasma levels of atrial natriuretic factor in cardiac allograft recipients: evidence of increased cardiac secretion and decreased renal clearance

  • Pharmacodynamics
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

The mechanism(s) causing high levels of plasma atrial natriuretic factor (ANF) in cardiac allograft recipients is(are) unclear. The kidney is important for the clearance of ANF and renal function may decline with cyclosporin A therapy in these patients. The relationship between plasma ANF level and renal function and also the pharmacokinetics of a continuous infusion of ANF (15.5 ng·kg−1·min−1 for 60 min) was examined in 6 cardiac allograft recipients on cyclosporin A therapy.

Resting plasma ANF levels were significantly higher in these patients than in 8 healthy subjects (71 vs. 21 ng·l−1). Both effective renal plasma flow (ERPF) and glomerular filtration rate (GFR) were significantly lower in these patients than in healthy subjects (215 vs. 617 ml·min−1 and 55 vs. 102 ml·min−1 respectively). There was a significant inverse correlation between plasma ANF and ERPF (r=-0.86) and between plasma ANF and GFR (r=-0.81). During the period of ANF infusion, steady state plasma ANF levels were significantly higher in cardiac allograft recipients. Total body clearance of ANF was marginally lower in these patients than in healthy subjects (60 vs. 10.0 l·min−1) although this difference did not reach statistical significance. Derived endogenous secretion rate of ANF was threefold higher in patients when compared to healthy subjects (633 vs. 208 ng·min−1).

We have therefore shown that cardiac allograft recipients on cyclosporin A have elevated plasma ANF levels and also decreased renal function. Pharmacokinetic analysis have shown that this increase in plasma ANF levels is due more to increased ANF secretion than to decreased ANF clearance in these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Singer DRJ, Buckley MG, MacGregor GA, Khayhani A, Banner NR, Yacoub MH (1986) Raised concentrations of plasma atrial natriuretic peptides in cardiac transplant recipients. Br Med J 293:1391–1392

    Google Scholar 

  2. Magovern JA, Pennock JL, Oaks TE, Campbell DB, Burg JE, Hersey RM (1987) Atrial natriuretic peptide in recipients of human orthotopic heart transplant. J Heart Transplant 6:193–198

    Google Scholar 

  3. Brouwer RM, Wenting GJ, Zijlstra F, Balk AHMM, Mochtar B, Derkx FHM, deBruin RJ, Weimar W, Schalenkamp MA (1988) Atrial wall stress rather than pressure per se might be responsible for the increased secretion of atrial natriuretic factor after heart transplantation. J Hypertens 6 (Suppl 4):330-S332

    Google Scholar 

  4. Crozier IG, Nicholls MG, Ikram H, Espiner EA, Yandle TG, Siegfried J (1986) Atrial natriuretic peptide in humans. Production and clearance by various tissues. Hypertension 8 (Suppl 2):11–15

    Google Scholar 

  5. Luft CF, Lang RE, Aronoff GR, Ruskaoho H, Toth M, Ganten D, Sterzel C, Unger T (1985) Atriopeptin III kinetics and pharmacodynamics in normal and in anephric rats. J Pharmacol Exp Ther 236:416–418

    Google Scholar 

  6. Myers BD, Ross J, Newton L, Luetscher J, Perboth M (1984) Cyclosporine-associated chronic nephropathy. N Engl J Med 311:699–705

    Google Scholar 

  7. Tan ACITL, Russell FM, Thien T, Benraad TJ (1993) Atrial natriuretic peptide: an overview of clinical pharmacology and pharmacokinetics. Clin Pharmacokinet 24:28–45

    Google Scholar 

  8. Biollaz J, Callahan LT, Nussberger J, Gomez HJ et al. (1987) Pharmacokinetics of synthetic atrial natriuretic peptide in normal men. Clin Pharmacol Ther 41:671–677

    Google Scholar 

  9. Hensen J, Abraham WT, Lesnefsky EJ, Levenson B, Groves BM et al. (1992) Atrial natriuretic peptide kinetic studies in patients with cardiac dysfunction. Kidney Int 42:1333–1339

    Google Scholar 

  10. Motwani JJ, Lang CC, Allen MJ, Johnson HJ, Struthers AD (1993) Dose-ranging effects of candoxatril on elimination of exogenous atrial natriuretic peptide in chronic heart failure. Clin Pharmacol Ther 54:661–669

    Google Scholar 

  11. Richards AM, Tonolo G, McIntyre GD, Leckie B, Robertson JIS (1987) Radioimmunoassay for plasma alpha human atrial natriuretic peptide: a comparison of direct and pre-extraced methods. J Hypertens 5:227–236

    Google Scholar 

  12. Lang CC, Choy AMJ, Balfour DJK, Struthers AD (1992) Prazosin attenuates the natriuretic response to atrial natriuretic factor in man. Kidney Int 42:433–441

    Google Scholar 

  13. Farge D, Couetil JP, Guillemain R, Viossat I, Chabrier PE, Braquet P, Carpentier A (1991) Atrial natriuretic factor after arthotopic heart transplantation (letter). N Engl J Med 324:777

    Google Scholar 

  14. Schiebinger RJ, Baker MZ, Linden J (1987) Effect of adrenergic and muscarinic cholinergic agonists on atrial natriuretic peptide secretion by isolated rat atria. Potential role of the autonomic nervous system in modulating atrial natriuretic peptide secretion. J Clin Invest 80:1687–1691

    Google Scholar 

  15. Lang CC, Struthers AD (1991) Interactions between atrial natriuretic factor and the autonomic nervous system. Clin Autonom Res 1:329–336

    Google Scholar 

  16. Goetz KL, Wong BC, Geer PG, Leadley RJ, Reinhardt HW (1986) Atrial stretch increases sodium excretion independently of release of atrial peptides. Am J Physiol 250:R946-R950

    Google Scholar 

  17. Starling RC, O'Dorisio TM, Malarkey WB, Murray KD, Myerowithz PD, Cody RJ (1991) Preserved atrial natriuretic peptide secretory function after cardiac transplantation. Am J Cardiol 68:237–241

    Google Scholar 

  18. Singer DRJ, Banner NR, Cox A, Patel N, Burdon M, Buckley MG, MacGregor GA, Yacoub MH (1990) Response to dynamic exercise in cardiac transplant recipients: implications for control of the sodium regulatory hormone atrial natriuretic peptide. Clin Sci 78:159–163

    Google Scholar 

  19. Schwab TR, Edwards BS, DeVries WC, Zimmerman RS, Burnett JC Jr (1986) Atrial endocrine function in humans with artificial hearts. N Engl J Med 315:1398–1401

    Google Scholar 

  20. Raine AEG (1990) Release of atrial natriuretic factor. In: Struthers AD (ed) Frontiers in pharmacology and therapeutics: atrial natriuretic factor. Blackwell, Oxford, pp 235–250

    Google Scholar 

  21. Hosenpud JD, Morton MJ, Wilson RA, Pantely GA, Normn DJ, Cobanoglu MA, Starr A (1989) Abnormal exercise hemodynamics in cardiac allograft recipients 1 year after cardiac transplantation. Relation to preload reserve. Circulation 80: 525–532

    Google Scholar 

  22. Lang CC, Prasad N, McAlpine HM, Lipworth BJ, MacDonald T, Struthers AD (1994) Increased levels of brain natriuretic peptide in patients with isolated diastolic dysfunction. Am Heart J 127:1635–1636

    Google Scholar 

  23. Gardner DG, Gertz BJ, Deschepper CF, Kim DY (1988) Gene for the rat atrial natriuretic peptide is regulated by glucocorticoids in vitro. J Clin Invest 82:127–1281

    Google Scholar 

  24. Gillies AH, Crozier IG, Nicholls MG, Espiner EA, Yandle TG (1987) Effect of posture on clearance of atrial natriuretic peptide from plasma. J Clin Endocrinol Metab 65:1095–1097

    Google Scholar 

  25. Cusson JR, duSouich P, Hamet P, Schiffrin EL, Kuchel O et al. (1988) Effects and pharmacokinetics of bolus injections of atrial natriuretic factor in normal volunteers. J Cardiovasc Pharmacol 11:635–642

    Google Scholar 

  26. Crozier IG, Nicholls MG, Ikram H, Espiner EA, Yandle TG, Jans S (1986) Atrial natriuretic peptide in humans — production and clearance by various tissues. Hypertension 8 (Suppl II):11–15

    Google Scholar 

  27. Olins GM, Spear KL, Siegel NR, Zurcher-Neely HA (1987) Inactivation of atrial natriuretic factor by the renal bush border. Biochem Biophys Acta 901:97–100

    Google Scholar 

  28. Almeida FA, Suzuki M, Scarborough RM, Lewicki JA, Maack T (1989) Clearance function of type C receptors of atrial natriuretic factor in rats. Am J Physiol 256:R469-R475

    Google Scholar 

  29. Kampmann JP, Hansen JM (1981) Glomerular filtration rate and creatinine clearance. Br J Pharmacol 12:7–14

    Google Scholar 

  30. Tomlanovich S, Golbetz H, Pelroth M, Stinson E, Myers BD (1980) Creatinine: An inadequate filtration marker in glomerular diseases. Am J Med 69:177–182

    Google Scholar 

  31. Tomlanovich S, Golbetz H, Pelroth M, Stinson E, Myers BD (1986) Limitations of creatinine in quantifying the severity of cyclosporine-induced chronic nephropathy. Am J Kidney Dis 8:332–337

    Google Scholar 

  32. Ohashi M, Fujio N, Nawata H, Kato KI, Matsuo H et al. (1987) Pharmacokinetics of synthetic α-human atrial natriuretic polypeptide in normal men: effect of aging. Regul Pept 19:265–272

    Google Scholar 

  33. Tan ACITL, Jansen TL, Thien TH, Termod EFS, Kloppenborg PWC, Benraad ThJ (1992) Kinetics of atrial natriuretic peptide in young and elderly subjects. Eur J Clin Pharmacol 42:449–452

    Google Scholar 

  34. Cody RJ, ATlas SA, Laragh JH, Kubo SH, Covit AB, Ryman KS, Shaknovich A et al. (1986) Atrial natriuretic factor in normal subjects and heart failure patients. J Clin Invest 78:1362–1374

    Google Scholar 

  35. Marleau S, Ong H, deLean A, duSouich P (1989) Disposition and dynamics of atrial natriuretic factor in conscious rabbits. J Pharmacol Exp Ther 251:328–333

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Clinical Pharmacology, Vanderbilt University School of Medicine, 37232-6602, Nashville, TN, USA

    C. C. Lang

  2. Departments of Clinical Pharmacology and Cardiology, Ninewells Hospital and Medical School, DD1 9SY, Dundee, UK

    T. Moreland, A. M. J. Choy, T. H. Pringle, G. P. McNeill & A. D. Struthers

Authors
  1. C. C. Lang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Moreland
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. M. J. Choy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T. H. Pringle
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G. P. McNeill
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. D. Struthers
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lang, C.C., Moreland, T., Choy, A.M.J. et al. Raised plasma levels of atrial natriuretic factor in cardiac allograft recipients: evidence of increased cardiac secretion and decreased renal clearance. Eur J Clin Pharmacol 48, 429–434 (1995). https://doi.org/10.1007/BF00194330

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00194330

Key words

Search

Navigation